As COVID-19 vaccines near final stages of testing, governments are also racing against each other, busy securing supply for their own countries even before key efficacy data readouts.

After signing on AstraZeneca and partner Oxford University for 100 million doses of their COVID-19 vaccine candidate, the UK government is nearing a £500 million ($625 million) deal with GlaxoSmithKline and Sanofi to buy 60 million doses of their investigative shot if it later proves successful, The Sunday Times reported. Source: Fierce Biotech 6/7/2020